ALK-rearranged pulmonary adenocarcinoma in Thai Patients: From diagnosis to treatment efficacy

BACKGROUND: Anaplastic lymphoma kinase (ALK) gene rearrangement is detected in 3 % to 13 % of non-small cell lung carcinoma patients, and these patients benefit from ALK inhibitors. The aim of this study was to determine the prevalence, the clinical and histological characteristics and the treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Incharoen, Pimpin, Reungwetwattana, Thanyanan, Saowapa, Sakditad, Kamprerasart, Kaettipong, Pangpunyakulchai, Duangjai, Arsa, Lalida, Jinawath, Artit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4855782/
https://www.ncbi.nlm.nih.gov/pubmed/27142166
http://dx.doi.org/10.1186/s12957-016-0893-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4855782/
https://www.ncbi.nlm.nih.gov/pubmed/27142166
http://dx.doi.org/10.1186/s12957-016-0893-6

Ejemplares similares